Role of CB2 in the Immune System Explained
Discover the critical role of CB2 receptors in the immune system, their interaction with cannabis compounds, and how they contribute to overall health.
Short answer: cannabinoid receptors sit in cell membranes all over the body, not in one place. CB1 receptors are packed into the brain and spinal cord, plus nerve endings in the gut, liver, fat tissue, muscle, and reproductive organs. CB2 receptors live mostly on immune cells, in the spleen, thymus, tonsils, lymph nodes, bone marrow, and gut wall, and they appear in the brain mainly when something is inflamed. THC plugs into both. Your own endocannabinoids, anandamide and 2-AG, get made on demand near these receptors and are broken down within minutes.
Role of CB2 in the Immune System Explained
CB1 is one of the most abundant G protein-coupled receptors in the mammalian brain. Look at a distribution map and the pattern is lopsided. Density runs high in the cerebral cortex, hippocampus, basal ganglia, cerebellum, amygdala, and hypothalamus. It runs low in the brainstem, which is part of why cannabis does not shut down breathing the way opioids can.
Location matters as much as density. CB1 sits mostly on the presynaptic side of a synapse, on the axon terminal of the sending neuron. When a neuron fires hard, it releases endocannabinoids that travel backward and dial down further release. That backward, or retrograde, signaling is the core trick of the endocannabinoid system. You also find CB1 inside mitochondria and on some peripheral nerve endings, which is why animal studies link it to pain sensing and energy use.
which receptors do cbd and thc activate
CB2 lives on immune tissue. Spleen, thymus, tonsils, lymph nodes, and bone marrow all carry it. On a cell level, B cells, natural killer cells, monocytes, and neutrophils express more of it than resting T cells do. In the central nervous system, microglia are the main CB2 carriers, and those numbers climb sharply during injury or neuroinflammation. In healthy brain tissue, CB2 levels are low.
cb1 and cb2 receptors explained
That upregulation is one reason researchers keep studying CB2 for pain, gut inflammation, and degenerative conditions. The receptor shows up where the trouble is.
CB1 and CB2 are the classics, but they are not the whole story. THC also activates TRPV1, the same channel capsaicin hits, which helps explain the warm, hot, sometimes irritating edge of high-THC flower. GPR55, GPR18, PPAR alpha and gamma, and the serotonin receptor 5-HT1A all respond to cannabinoids in lab work. Some researchers call these expanded targets part of the endocannabinoid system. Others keep the label narrow and call them cannabinoid-sensitive receptors instead. The debate is real and not settled.
Effects follow receptor geography. Hippocampus CB1 activity lines up with short-term memory disruption. Cerebellar CB1 tracks with coordination and balance. Basal ganglia involvement shows up in movement and reward. Amygdala and cortical signaling track with anxiety and mood, which is why the same strain can calm one person and spike paranoia in another.
CBD behaves differently. It binds CB1 and CB2 weakly, and it acts as a negative allosteric modulator at CB1, meaning it changes how THC and endocannabinoids signal without flipping the switch itself. That is why CBD on its own does not produce a strong high, and why it can take the edge off a THC dose.
If you want a mental model, think of CB1 as the nervous system's volume knob and CB2 as the immune system's. Both are spread across the body, both respond to plant cannabinoids, and where they sit explains most of what you feel.